Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67026 - 67050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	EDNRB	1910	upregulated	rosiglitazone results in increased expression of EDNRB mRNA	13q22.3	A24115
Rosiglitazone	Approved Investigational	EHF	26298	upregulated	rosiglitazone results in increased expression of EHF mRNA	11p13	A10216
Rosiglitazone	Approved Investigational	ELK4	2005	upregulated	rosiglitazone results in increased expression of ELK4 mRNA	1q32.1	A20427
Rosiglitazone	Approved Investigational	EML4	27436	upregulated	rosiglitazone results in increased expression of EML4 mRNA	2p21	A10216
Rosiglitazone	Approved Investigational	ENTPD7	57089	downregulated	rosiglitazone results in decreased expression of ENTPD7 mRNA	10q24.2	A20427
Rosiglitazone	Approved Investigational	ENTPD8	377841	downregulated	rosiglitazone results in decreased expression of ENTPD8 mRNA	9q34.3	A22609
Rosiglitazone	Approved Investigational	ERP27	121506	downregulated	rosiglitazone results in decreased expression of ERP27 mRNA	12p12.3	A22609
Rosiglitazone	Approved Investigational	ESPN	83715	downregulated	rosiglitazone results in decreased expression of ESPN mRNA	1p36.31	A22609
Rosiglitazone	Approved Investigational	ESRRG	2104	downregulated	rosiglitazone results in decreased expression of ESRRG mRNA	1q41	A22609
Rosiglitazone	Approved Investigational	ETNK2	55224	downregulated	rosiglitazone results in decreased expression of ETNK2 mRNA	1q32.1	A22609
Rosiglitazone	Approved Investigational	ETS2	2114	upregulated	rosiglitazone results in increased expression of ETS2 mRNA	21q22.2	A10216
Rosiglitazone	Approved Investigational	F10	2159	downregulated	rosiglitazone results in decreased expression of F10 mRNA	13q34	A22609
Rosiglitazone	Approved Investigational	F12	2161	downregulated	rosiglitazone results in decreased expression of F12 mRNA	5q35.3	A22609
Rosiglitazone	Approved Investigational	F7	2155	downregulated	rosiglitazone results in decreased expression of F7 mRNA	13q34	A22609
Rosiglitazone	Approved Investigational	FABP4	2167	upregulated	rosiglitazone results in increased expression of FABP4 mRNA	8q21.13	A23064 A24109 A24097 A24116 A10216 A24098 A22609 A20427
Rosiglitazone	Approved Investigational	FAM102A	399665	upregulated	rosiglitazone results in increased expression of FAM102A mRNA	9q34.11	A22609
Rosiglitazone	Approved Investigational	FAM109A	144717	downregulated	rosiglitazone results in decreased expression of FAM109A mRNA	12q24.12	A10216
Rosiglitazone	Approved Investigational	FAM111A	63901	downregulated	rosiglitazone results in decreased expression of FAM111A mRNA	11q12.1	A22609
Rosiglitazone	Approved Investigational	FAM214A	56204	downregulated	rosiglitazone results in decreased expression of FAM214A mRNA	15q21.2-q21.3	A20427
Rosiglitazone	Approved Investigational	FAR2	55711	upregulated	rosiglitazone results in increased expression of FAR2 mRNA	12p11.22	A10216
Rosiglitazone	Approved Investigational	FAS	355	upregulated	rosiglitazone results in increased expression of FAS mRNA	10q23.31	A20877
Rosiglitazone	Approved Investigational	FASN	2194	upregulated	rosiglitazone results in increased expression of FASN mRNA	17q25.3	A24116 A23178
Rosiglitazone	Approved Investigational	FBXO15	201456	upregulated	rosiglitazone results in increased expression of FBXO15 mRNA	18q22.3	A10216
Rosiglitazone	Approved Investigational	FGF21	26291	upregulated	rosiglitazone results in increased expression of FGF21 mRNA	19q13.33	A21417
Rosiglitazone	Approved Investigational	FGFR1OP	11116	downregulated	rosiglitazone results in decreased expression of FGFR1OP mRNA	6q27	A24100

Displaying entries 67026 - 67050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability